1. Home
  2. RGEN vs INGR Comparison

RGEN vs INGR Comparison

Compare RGEN & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$179.65

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Logo Ingredion Incorporated

INGR

Ingredion Incorporated

N/A

Current Price

$94.81

Market Cap

6.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
INGR
Founded
1981
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
6.3B
IPO Year
1995
1997

Fundamental Metrics

Financial Performance
Metric
RGEN
INGR
Price
$179.65
$94.81
Analyst Decision
Buy
Hold
Analyst Count
22
7
Target Price
★ $189.70
$121.50
AVG Volume (30 Days)
★ 880.1K
525.0K
Earning Date
10-27-2026
11-03-2026
Dividend Yield
N/A
★ 3.46%
EPS Growth
★ 286.96
15.14
EPS
0.24
★ 4.01
Revenue
$141,236,000.00
★ $7,219,000,000.00
Revenue This Year
$12.04
N/A
Revenue Next Year
$17.80
$1.64
P/E Ratio
$805.46
★ $24.03
Revenue Growth
★ 35.10
N/A
52 Week Low
$100.99
$94.44
52 Week High
$198.87
$123.49

Technical Indicators

Market Signals
Indicator
RGEN
INGR
Relative Strength Index (RSI) 63.35 29.00
Support Level $159.22 $94.44
Resistance Level N/A $100.38
Average True Range (ATR) 6.58 1.66
MACD 0.98 -0.22
Stochastic Oscillator 75.63 4.84

Price Performance

Historical Comparison
RGEN
INGR

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins. The company plans to acquire Tate & Lyle in an all-cash deal that should close in 2027.

Share on Social Networks: